Min Ye,Yingnan Chen,Margaret Favata,Yvonne Lo,Alexander Sokolsky,Sarah Winterton,Liangxing Wu,Wenqing Yao
申请号：
US16791561
公开号：
US20200316064A1
申请日:
2020.02.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Biomarkers are provided that are predictive and/or indicative of a subject's responsiveness to a cyclin-dependent kinase 2 (CDK2) inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing a disease or disorder associated with CDK2 and for monitoring treatment.
